Trial Profile
Effect of Combination Therapy with Intravitreal Aflibercept and Verteporfin Photodynamic Therapy in Patients with Polypoidal Choroidal Vasculopathy: A Prospective Case-series Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jan 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Verteporfin (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 30 Aug 2017 New trial record